Criteria-Based Rehabilitation Following Revision Hip Arthroscopy: A Clinical Commentary by Haley Leo, Trevor Shelton, Helen Bradley

“…This criterion based progression promotes range of motion (ROM), strength, gait, neuromuscular control, load introduction and gradual return to play…”
Get full text

GERD—Barrett—Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers? by Romana Illig, Eckhard Klieser, Tobias Kiesslich, Daniel Neureiter

“…The GERD-Barrett-Adenocarcinoma sequence currently lacks well-defined diagnostic, progressive, predictive, and prognostic biomarkers (i) providing an appropriate screening method identifying the presence of the disease, (ii) estimating the risk of evolving cancer, that is, the progression from Barrett’s esophagus (BE) to esophageal adenocarcinoma (EAC), (iii) predicting the response to therapy, and (iv) indicating an overall survival—prognosis for EAC patients. …”
Get full text

Superficial Bladder Cancer Therapy by Emmanuel Schenkman, Donald L. Lamm

“…Intravesical chemotherapy reduces short-term tumor recurrence by about 20%, and long-term recurrence by about 7%, but has not reduced progression or mortality. Presently, BCG immunotherapy remains the most effective treatment and prophylaxis for TCC (Ta, T1, CIS) and reduces tumor recurrence, disease progression, and mortality. …”
Get full text

GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma by Shujie Wang, Tongjia Zhang, Yue Zhou, Zitao Jiao, Kejia Lu, Xinyi Liu, Wei Jiang, Zhe Yang, Hui Li, Xiaowei Zhang

“…Abnormally high expression of Golgi protein 73 (GP73) and pyruvate kinase M2 (PKM2) is intimately associated with HCC progression. However, as secreted proteins, the role of their extracellular secretions in HCC progression remains unclear. …”
Get full text

Construction Payment Automation Through Scan-to-BIM and Blockchain-Enabled Smart Contract by Hamdy Elsharkawi, Emad Elbeltagi, Mohamed S. Eid, Wael Alattyih, Hossam Wefki

“…This study leveraged accurate, real-time building progress data to automate payments using blockchain-enabled smart contracts upon work completion, thus reducing payment disputes by tying payments to verifiable construction progress, leading to faster release of payments. …”
Get full text

PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma by San-Chi Chen, Hsiang-Ling Ho, Chien-An Liu, Yi‑Ping Hung, Nai-Jung Chiang, Ming‑Huang Chen, Yee Chao, Muh-Hwa Yang

“…Imaging showed 71.0% objective response in the regression group, 50.0% stable disease in the stable group, and 83.7% progressive disease in the progression group (p < 0.001). …”
Get full text

Deciphering Parkinson’s Disease through Eye Movements: A Promising Tool for Early Diagnosis in the Face of Cognitive Impairment by Xianglian Liao, Jian Yao, Hongyin Tang, Yilan Xing, Xin Zhao, Daao Nie, Ping Luan, Guihua Li

“…However, there is still a lack of effective biomarkers to evaluate the decline in cognitive function and predict the progression of the disease, especially in the early stage. …”
Get full text

Short-Term and Long-Term Effects of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review by Erika Butkutė, Monika Zieniūtė, Agnė Morkūnaitė, Vilma Jūratė Balčiūnienė

“…Rapid glycemic changes after surgery may pose risks of DR progression. Large-scale, longitudinal studies are needed to clarify the role of BS in DR progression and regression.…”
Get full text

Une approche sociologique des problèmes environnementaux : deux hypothèses explicatives by Jean-Luc Roques

“…The first one results from an always long-lived faith in the myth of the progress, belief that technical progress could solve all problems. …”
Get full text

Le Bilan Sociétal© : de la prise en compte des intérêts contradictoires des parties prenantes à la responsabilité sociétale by Catherine Bodet, Dominique Picard

“…It also increases the involvement of actors on social and environment, consequently strengthened a forward march to progress.…”
Get full text

Bilevel Programming for Traffic Signal Coordinated Control considering Pedestrian Crossing by Dawei Li, Yuchen Song, Qiong Chen

“…Firstly, the model of progression band in adjacent intersections is analyzed comprehensively, and the calculation formulas of progression bandwidth and the delay of vehicles which are from the progression of traffic flow under different conditions are given. …”
Get full text

Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy by Haolun Ding, Min Yuan, Yaning Yang, Xu Steven Xu

“…Mutation levels rose prior to radiographic progression in most progressing patients, with specific mutations (SPTA1, STK11, KEAP1, SMARCA4, TBX3, CDH2, and MLL3) significantly enriched in those with progression or nondurable response. …”
Get full text

Utilizing fuzzy banana curve for project monitoring and control by Mahmood Jahanbani, Hamid Shahbandarzadeh

“…A key responsibility of project management is to control and monitor project progress. One commonly used tool is the S-curve, which highlights any deviations from the project plan. …”
Get full text

VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease by Tonya N. Taylor, W. Michael Caudle, Gary W. Miller

“…With a 95% reduction in VMAT2 expression, VMAT2-deficient animals have decreased motor function, progressive deficits in olfactory discrimination, shorter latency to behavioral signs of sleep, delayed gastric emptying, anxiety-like behaviors at younger ages, and a progressive depressive-like phenotype. …”
Get full text

Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma by A. A. Formozo, J. R. Gomes, R. A. Schmerling, A. C. Buzaid

“…Most of the patients received the second course after six months or more from the first treatment with ipilimumab. The median progression-free survival (mPFS) of the treatment with ipilimumab was 8.9 months, and the median progression-free survival of the second course was 6.3 months. …”
Get full text

Superficial Siderosis and Anticoagulation Therapy: Different Presentations, Different Outcomes by Rui Duarte Barreto, Luís Ruano, Vítor Tedim Cruz, Carlos Veira, Paula Coutinho

“…Two Caucasian women, both under long-term oral anticoagulation: a 74 year old woman with slowly progressive hearing loss and mild cerebellar ataxia; a 72 year old woman suffering from behavioural changes, rapidly progressive cognitive decline and latter developing paraparesis. …”
Get full text

Folded and Unfolded Conformations of Proteins Involved in Pancreatic Cancer: a Layman's Guide by Jerónimo Bravo, José L. Neira

“…Since cancer deregulation and progression are associated with changes in at least one biochemical pathway, the knowledge of the structure of the proteins involved in such routes seems to be crucial in order to understand how this cancer progresses and, more importantly, to design more efficient and rationally designed drugs. …”
Get full text

Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results by Adam Stepien, Natalia L. Dabrowska, Marzena Maciagowska, Renata Piusinska Macoch, Aleksandra Zolocinska, Slawomir Mazur, Katarzyna Siennicka, Emilia Frankowska, Rafał Kidzinski, Małgorzata Chalimoniuk, Zygmunt Pojda

“…Our results indicate that ASC therapy is safe and does not produce any substantial side effects. Disease progression-free survival (PFS) of 18 months was seen in all patients with RRMS and SPMS. …”
Get full text

Navigating technological innovation and rising costs: Assessing economic performance in Chinese manufacturing. by Songling Wu, Yanqi Si, Xiaoxiang Wang

“…The findings highlight technological progress as the primary driver of economic growth within the Chinese manufacturing sector. …”
Get full text

RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA by Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone

“… Multiple myeloma (MM) is a disorder of the monoclonal plasma cells and is the second most common hematologic malignancy. MM initiation and progression are dependent upon complex genomic abnormalities. …”
Get full text